These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Heterogeneity of breast cancer: etiology and clinical relevance. Almendro V; Fuster G Clin Transl Oncol; 2011 Nov; 13(11):767-73. PubMed ID: 22082639 [TBL] [Abstract][Full Text] [Related]
7. Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer. Kündig P; Giesen C; Jackson H; Bodenmiller B; Papassotirolopus B; Freiberger SN; Aquino C; Opitz L; Varga Z J Transl Med; 2018 May; 16(1):118. PubMed ID: 29739401 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. Brooks MD; Burness ML; Wicha MS Cell Stem Cell; 2015 Sep; 17(3):260-71. PubMed ID: 26340526 [TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells: implications for cancer therapy. Dawood S; Austin L; Cristofanilli M Oncology (Williston Park); 2014 Dec; 28(12):1101-7, 1110. PubMed ID: 25510809 [TBL] [Abstract][Full Text] [Related]
10. Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy. Koren S; Bentires-Alj M Mol Cell; 2015 Nov; 60(4):537-46. PubMed ID: 26590713 [TBL] [Abstract][Full Text] [Related]
11. Stem cells of the breast and cancer therapy. Groner B; Vafaizadeh V; Brill B; Klemmt P Womens Health (Lond); 2010 Mar; 6(2):205-19. PubMed ID: 20187727 [TBL] [Abstract][Full Text] [Related]
12. Biological progression of breast cancer and clinical implications. Vici P; Sergi D; Pizzuti L; Vincenzoni C; Baiocco E; Mancini E; Lopez M; Vizza E; Lauro LD Clin Ter; 2011; 162(4):297-9. PubMed ID: 21912815 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer intratumor genetic heterogeneity: causes and implications. Ng CK; Pemberton HN; Reis-Filho JS Expert Rev Anticancer Ther; 2012 Aug; 12(8):1021-32. PubMed ID: 23030222 [TBL] [Abstract][Full Text] [Related]
14. Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer. Zhang M; Tsimelzon A; Chang CH; Fan C; Wolff A; Perou CM; Hilsenbeck SG; Rosen JM Cancer Discov; 2015 May; 5(5):520-33. PubMed ID: 25735774 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications. Deng Q; Tang DG Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606 [TBL] [Abstract][Full Text] [Related]
16. Surgical impact of new treatments in breast cancer. Alkatout I; Order B; Klapper W; Weigel MT; Jonat W; Schaefer FK; Mundhenke C; Wenners A Minerva Ginecol; 2013 Aug; 65(4):363-83. PubMed ID: 24051938 [TBL] [Abstract][Full Text] [Related]
17. Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles. Sansone P; Berishaj M; Rajasekhar VK; Ceccarelli C; Chang Q; Strillacci A; Savini C; Shapiro L; Bowman RL; Mastroleo C; De Carolis S; Daly L; Benito-Martin A; Perna F; Fabbri N; Healey JH; Spisni E; Cricca M; Lyden D; Bonafé M; Bromberg J Cancer Res; 2017 Apr; 77(8):1927-1941. PubMed ID: 28202520 [TBL] [Abstract][Full Text] [Related]
18. Insights into the cell of origin in breast cancer and breast cancer stem cells. Lindeman GJ; Visvader JE Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420 [TBL] [Abstract][Full Text] [Related]
19. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment. Apostoli AJ; Ailles L Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062 [TBL] [Abstract][Full Text] [Related]